Please use this identifier to cite or link to this item:
|Title:||Feasibility and acceptance of a pharmacist-run Tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients||Authors:||Yap, K.Y.-L.
|Keywords:||ambulatory cancer patients
chemotherapy-induced nausea and vomiting
pharmacist-run tele-oncology service
post-chemotherapy symptom management
short message service technology
side effect telemonitoring
|Issue Date:||1-May-2013||Citation:||Yap, K.Y.-L., Low, H.X., Koh, K.S., Un, M., Shih, V., Chan, A. (2013-05-01). Feasibility and acceptance of a pharmacist-run Tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients. Telemedicine and e-Health 19 (5) : 387-395. ScholarBank@NUS Repository. https://doi.org/10.1089/tmj.2012.0136||Abstract:||Background: The use of telemedicine for cancer patients is limited, particularly in Asia. These patients need to be monitored because more are being treated as outpatients, so that any treatment-related side effects can be managed. We assessed the feasibility and acceptance of a pharmacist-run tele-oncology service to monitor chemotherapy-induced nausea and vomiting (CINV) in ambulatory cancer patients. Patients and Methods: A single-center, prospective study was conducted at a local cancer center. Patients' CINV symptoms were monitored through short message service (SMS) for 5 days post-chemotherapy. Feasibility was measured by patients' adherence to the service, patient satisfaction, and number of pharmacist interventions. Acceptance was measured by the accrual rate. Results: The accrual rate was 37.6% (68/181 patients). Sixty patients (median age, 49.5 years) completed the study. Overall adherence was 73.3%. The majority (90.0%) were comfortable with the duration of SMS monitoring, especially adherent patients (95.5% versus 75.0%, p=0.038). Over half (61.7%) found the SMS advice useful. Twenty-two intervention calls were made by pharmacists for uncontrolled CINV. Conclusions: A pharmacist-run tele-oncology service for real-time monitoring of CINV is feasible in ambulatory cancer patients. Incorporating the monitoring of other side effects will enhance its value and acceptance by patients for post-chemotherapy symptom management. © 2013, Mary Ann Liebert, Inc. 2013.||Source Title:||Telemedicine and e-Health||URI:||http://scholarbank.nus.edu.sg/handle/10635/105957||ISSN:||15305627||DOI:||10.1089/tmj.2012.0136|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 29, 2021
WEB OF SCIENCETM
checked on Nov 29, 2021
checked on Dec 2, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.